Diclofenac potassium

Suppliers

Names

[ Name ]:
Diclofenac potassium

[Synonym ]:
Diclofenic potassium
Potassium {2-[(2,6-dichlorophenyl)amino]phenyl}acetate
Benzeneacetic acid, 2-[(2,6-dichlorophenyl)amino]-, potassium salt (1:1)
potassium 2-(2-(2,6-dichlorophenylamino)phenyl)acetate
2-((2,6-Dichlorophenyl)amino)benzeneacetic Acid Monopotassium Salt
Diclofenac potassium
2-{2-[(2,6-dichlorophenyl)amino]phenyl}acetic acid, potassium salt
Potassium [2-[(2,6-dichlorophenyl)amino]phenyl]acetate
UNII-L4D5UA6CB4
MFCD00082254
Cataflam
CGP 45840B
CGP-45840B
2-[(2,6-Dichlorophenyl)amino]benzeneacetic acid potassium salt, Diclofenac potassium salt

Chemical & Physical Properties

[ Boiling Point ]:
412ºC at 760 mmHg

[ Melting Point ]:
156-158ºC

[ Molecular Formula ]:
C₁₄H₁₀Cl₂KNO₂

[ Molecular Weight ]:
334.239

[ Flash Point ]:
203ºC

[ Exact Mass ]:
332.972565

[ PSA ]:
52.16000

[ LogP ]:
3.10240

[ Vapour Pressure ]:
1.59E-07mmHg at 25°C

Safety Information

[ Symbol ]:

GHS07, GHS09

[ Signal Word ]:
Warning

[ Hazard Statements ]:
H302-H411

[ Precautionary Statements ]:
P301 + P312 + P330

[ Hazard Codes ]:
T: Toxic;

[ Risk Phrases ]:
22-51/53

[ Safety Phrases ]:
61

[ RIDADR ]:
2811.0

[ HS Code ]:
2922499990

Customs

[ HS Code ]: 2922499990

[ Summary ]:
HS:2922499990 other amino-acids, other than those containing more than one kind of oxygen function, and their esters; salts thereof VAT:17.0% Tax rebate rate:9.0% Supervision conditions:AB(certificate of inspection for goods inward,certificate of inspection for goods outward) MFN tariff:6.5% General tariff:30.0%

Articles

The advantages and limitations of the analgesics available for control of postoperative pain after a dental procedure.

SAAD Dig. 29 , 70-81, (2013)

Chitosan/glucose 1-phosphate as new stable in situ forming depot system for controlled drug delivery.

Eur. J. Pharm. Biopharm. 88(2) , 361-73, (2014)

Chitosan (CS)-based thermosensitive solutions that turn into semi-solid hydrogels upon injection at body temperature have increasingly drawn attention over the last decades as an attractive new type o...

Cystoid macular edema from cancer-associated retinopathy.

Optom. Vis. Sci. 91(4 Suppl 1) , S66-70, (2014)

This article reviews the diagnosis and management of a patient with cancer-associated retinopathy (CAR) secondary to small cell lung cancer who developed a rare presentation of CAR, cystoid macular ed...